Chemotherapy Delivered After Viral Immunogene Therapy Augments Antitumor Efficacy Via Multiple Immune-mediated Mechanisms

Harris, 1976, The effect of immunosuppressive chemotherapy on immune function in patients with malignant disease, Cancer, 37, 1058, 10.1002/1097-0142(197602)37:2+<1058::AID-CNCR2820370813>3.0.CO;2-O Gulley, 2007, Enhancing efficacy of therapeutic vaccinations by combination with other modalities, Vaccine, 25, B89, 10.1016/j.vaccine.2007.04.091 Nowak, 2003, Synergy between chemotherapy and immunotherapy in the treatment of established murine solid tumors, Cancer Res, 63, 4490 Ramakrishnan, 2008, Combined modality immunotherapy and chemotherapy: a new perspective, Cancer Immunol Immunother, 57, 1523, 10.1007/s00262-008-0531-4 van der Most, 2006, Cranking the immunologic engine with chemotherapy: using context to drive tumor antigen cross-presentation towards useful antitumor immunity, Cancer Res, 66, 601, 10.1158/0008-5472.CAN-05-2967 Zitvogel, 2008, Immunological aspects of cancer chemotherapy, Nat Rev Immunol, 8, 59, 10.1038/nri2216 Zitvogel, 2008, The anticancer immune response: indispensable for therapeutic success, J Clin Invest, 118, 1991, 10.1172/JCI35180 Lake, 2005, Immunotherapy and chemotherapy–a practical partnership, Nat Rev Cancer, 5, 397, 10.1038/nrc1613 Antonia, 2006, Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancer, Clin Cancer Res, 12, 878, 10.1158/1078-0432.CCR-05-2013 Gribben, 2005, Unexpected association between induction of immunity to the universal tumor antigen CYP1B1 and response to next therapy, Clin Cancer Res, 11, 4430, 10.1158/1078-0432.CCR-04-2111 Arlen, 2006, A randomized phase II study of concurrent docetaxel plus vaccine versus vaccine alone in metastatic androgen-independent prostate cancer, Clin Cancer Res, 12, 1260, 10.1158/1078-0432.CCR-05-2059 Gilboa, 2004, The promise of cancer vaccines, Nat Rev Cancer, 4, 401, 10.1038/nrc1359 Harrop, 2006, Viral vectors for cancer immunotherapy, Front Biosci, 11, 804, 10.2741/1838 Sterman, 2007, A phase I clinical trial of single-dose intrapleural IFN-β gene transfer for malignant pleural mesothelioma and metastatic pleural effusions: high rate of antitumor immune responses, Clin Cancer Res, 13, 4456, 10.1158/1078-0432.CCR-07-0403 Suzuki, 2005, Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity, Clin Cancer Res, 11, 6713, 10.1158/1078-0432.CCR-05-0883 Zhong, 2007, Low-dose paclitaxel prior to intratumoral dendritic cell vaccine modulates intratumoral cytokine network and lung cancer growth, Clin Cancer Res, 13, 5455, 10.1158/1078-0432.CCR-07-0517 Pardoll, 2003, Does the immune system see tumors as foreign or self, Annu Rev Immunol, 21, 807, 10.1146/annurev.immunol.21.120601.141135 Curiel, 2008, Regulatory T cells and treatment of cancer, Curr Opin Immunol, 20, 241, 10.1016/j.coi.2008.04.008 Gallina, 2006, Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells, J Clin Invest, 116, 2777, 10.1172/JCI28828 Kim, 2008, B-cell depletion using an anti-CD20 antibody augments antitumor immune responses and immunotherapy in nonhematopoetic murine tumor models, J Immunother, 31, 446, 10.1097/CJI.0b013e31816d1d6a Nowak, 2003, Induction of tumor cell apoptosis in vivo increases tumor antigen cross-presentation, cross-priming rather than cross-tolerizing host tumor-specific CD8 T cells, J Immunol, 170, 4905, 10.4049/jimmunol.170.10.4905 Haas, 2006, Cycloxygenase-2 inhibition augments the efficacy of a cancer vaccine, Clin Cancer Res, 12, 214, 10.1158/1078-0432.CCR-05-1178 Lambright, 2001, Inclusion of the herpes simplex thymidine kinase gene in a replicating adenovirus does not augment antitumor efficacy, Gene Ther, 8, 946, 10.1038/sj.gt.3301489 Vile, 1994, Systemic gene therapy of murine melanoma using tissue specific expression of the HSVtk gene involves an immune component, Cancer Res, 54, 6228 Shibata, 2008, Antimetastatic effect of suicide gene therapy for mouse mammary cancers requires T-cell-mediated immune responses, Med Mol Morphol, 41, 34, 10.1007/s00795-007-0388-1 Suzuki, 2007, Gemcitabine has significant immunomodulatory activity in murine tumor models independent of its cytotoxic effects, Cancer Biol Ther, 6, 880, 10.4161/cbt.6.6.4090 Sica, 2006, Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy, Eur J Cancer, 42, 717, 10.1016/j.ejca.2006.01.003 Kjaergaard, 1999, Tumor infiltration by adoptively transferred T cells is independent of immunologic specificity but requires down-regulation of L-selectin expression, J Immunol, 163, 751 Cohen, 2001, T-cell adoptive therapy of tumors: mechanisms of improved therapeutic performance, Crit Rev Immunol, 21, 215 Nowak, 2002, Gemcitabine exerts a selective effect on the humoral immune response: implications for combination chemo-immunotherapy, Cancer Res, 62, 2353 Spisek, 2007, Towards a better way to die with chemotherapy: role of heat shock protein exposure on dying tumor cells, Cell Cycle, 6, 1962, 10.4161/cc.6.16.4601 Obeid, 2007, Calreticulin exposure dictates the immunogenicity of cancer cell death, Nat Med, 13, 54, 10.1038/nm1523 Apetoh, 2007, The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy, Immunol Rev, 220, 47, 10.1111/j.1600-065X.2007.00573.x Vo, 2009, Enhanced antitumor activity induced by adoptive T-cell transfer and adjunctive use of the histone deacetylase inhibitor LAQ824, Cancer Res, 69, 8693, 10.1158/0008-5472.CAN-09-1456 Ramakrishnan, 2010, Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice, J Clin Invest, 120, 1111, 10.1172/JCI40269 Arlt, 2003, Role of NF-kappaB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death, Oncogene, 22, 3243, 10.1038/sj.onc.1206390 Jones, 2000, Inhibition of NF-kappaB sensitizes non-small cell lung cancer cells to chemotherapy-induced apoptosis, Ann Thorac Surg, 70, 930, 10.1016/S0003-4975(00)01635-0 Haefner, 2002, NF-kappa B: arresting a major culprit in cancer, Drug Discov Today, 7, 653, 10.1016/S1359-6446(02)02309-7 Machiels, 2001, Cyclophosphamide, doxorubicin, and paclitaxel enhance the antitumor immune response of granulocyte/macrophage-colony stimulating factor-secreting whole-cell vaccines in HER-2/neu tolerized mice, Cancer Res, 61, 3689 Yu, 2003, Effective combination of chemotherapy and dendritic cell administration for the treatment of advanced-stage experimental breast cancer, Clin Cancer Res, 9, 285 Prell, 2006, The anti-tumor efficacy of a GM-CSF-secreting tumor cell vaccine is not inhibited by docetaxel administration, Cancer Immunol Immunother, 55, 1285, 10.1007/s00262-005-0116-4 Garnett, 2008, Combination of docetaxel and recombinant vaccine enhances T-cell responses and antitumor activity: effects of docetaxel on immune enhancement, Clin Cancer Res, 14, 3536, 10.1158/1078-0432.CCR-07-4025 Merritt, 2003, Cisplatin augments cytotoxic T-lymphocyte-mediated antitumor immunity in poorly immunogenic murine lung cancer, J Thorac Cardiovasc Surg, 126, 1609, 10.1016/S0022-5223(03)00707-4 Wilderman, 2005, Intrapulmonary IFN-β gene therapy using an adenoviral vector is highly effective in a murine orthotopic model of bronchogenic adenocarcinoma of the lung, Cancer Res, 65, 8379, 10.1158/0008-5472.CAN-05-0920 Lin, 1996, Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen, Cancer Res, 56, 21 Fitzpatrick, 1994, Transforming growth factor-β: antisense RNA-mediated inhibition affects anchorage-independent growth, tumorigenicity and tumor-infiltrating T-cells in malignant mesothelioma, Growth Factors, 11, 29, 10.3109/08977199409015049 Wilderman, 2006, Blockade of TNF-α decreases both inflammation and efficacy of intrapulmonary Ad.IFNβ immunotherapy in an orthotopic model of bronchogenic lung cancer, Mol Ther, 13, 910, 10.1016/j.ymthe.2005.12.012 Brin, 2006, Adenovirus delivery provides extended interferon-α exposure and augments treatment of metastatic carcinoma, Cancer Gene Ther, 13, 664, 10.1038/sj.cgt.7700942 Smythe, 1994, Use of recombinant adenovirus to transfer the herpes simplex virus thymidine kinase (HSVtk) gene to thoracic neoplasms: an effective in vitro drug sensitization system, Cancer Res, 54, 2055 Jassar, 2005, Activation of tumor-associated macrophages by the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid induces an effective CD8+ T-cell-mediated antitumor immune response in murine models of lung cancer and mesothelioma, Cancer Res, 65, 11752, 10.1158/0008-5472.CAN-05-1658